Molina Healthcare AI Stock Analysis
Want to see MOH full AI Analyst Report?
Molina Healthcare (MOH) AI Stock Analysis
Molina Healthcare
(NYSE:MOH)
MOH scores as mid-range: the largest drag is weakened financial performance (profitability compression, TTM net loss, and cash-flow volatility). Offsetting this are constructive technicals (price above key moving averages with positive momentum) and an encouraging earnings-call outlook with reaffirmed 2026 guidance and stronger 2027 earnings building blocks, though elevated medical cost trend and membership attrition remain notable risks. Valuation is also a headwind given the negative P/E and lack of dividend yield data.
Molina Healthcare Key Performance Indicators (KPIs)
Total MembersTracks the total number of individuals enrolled in Molina Healthcare plans, indicating market reach and potential revenue base.
Membership moves in sharp step‑changes (late‑2021 and early‑2024) rather than steady organic growth, suggesting wins/losses or policy shifts drive volumes. The abrupt drop through early‑mid 2026 wipes out much of the 2024–25 gains, implying a material contract loss or Medicaid redetermination impact that will meaningfully reduce revenue visibility and could pressure margins if the lost lives were lower‑cost. Treat membership as binary event risk — monitor state renewals, redetermination trends and management’s commentary on retention or replacement contracts for guidance on near‑term results.
Molina Healthcare (MOH) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $11.55B
- Dividend Yield
- ―
- Average Volume (3M)
- 779.97K
- Price to Earnings (P/E)
- -364.7
- Beta (1Y)
- -0.16
- Revenue Growth
- -0.95%
- EPS Growth
- -105.84%
- Country
- US
- Employees
- 19,000
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Plans
Molina Healthcare Business Overview & Revenue Model
Company Description
Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare program...
How the Company Makes Money
Molina Healthcare makes money primarily by operating managed health plans under contracts with government agencies and, in some cases, through participation in government-sponsored insurance programs. Its core revenue model is based on premiums (ofte...
Molina Healthcare Earnings Call Summary
The call was broadly optimistic. Third-quarter results were in line with expectations, 2026 guidance was reaffirmed, the balance sheet remained strong, and management highlighted improving Medicaid rate conditions, strong duals performance, the successful Florida CMS implementation, and preliminary 2027 earnings building blocks above $9.50 per share. The main challenges were elevated medical cost trend, membership declines, current-year MAPD and Marketplace losses, the initial Florida CMS loss, and delays to the Georgia and Texas contracts. Overall, the number and significance of the positive developments outweighed the stated challenges.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For 2026, Molina reaffirmed premium revenue guidance of approximately $42 billion and adjusted earnings guidance of at least $5.25 per share, with consolidated MCR at 92.6%, adjusted G&A ratio at approximately 6.4%, Medicaid MCR at 92.9%, Medicare MCR at 92.2%, and Marketplace MCR at 90%; guidance now includes rates at 4.5% and trend at 5.5%, with implied fourth quarter adjusted EPS of $0.50, Medicaid MCR of 93.6% (92.5% excluding Florida CMS), Medicare MCR of 94.7%, and Marketplace MCR of 96.1%. For 2027, premium revenue is expected to be at least $45 billion, preliminary EPS building blocks sum to more than $9.50 per share, known embedded earnings remain approximately $9 per share, and $4 per share of embedded earnings is expected to be harvested, while Medicaid rates may approximate 6%, medical cost trend is projected in a range of 5.5%-6% including 50 basis points of conservatism, membership attrition is expected to be 6%, Marketplace is expected to reach at least breakeven, and every 100 basis points of Medicaid MCR is worth approximately $5 per share.
Molina Healthcare Financial Statement Overview
Summary
Financials look pressured and transitional. Profitability deteriorated sharply versus 2023–2024, with 2025 margin compression and TTM moving to a small net loss. Leverage is moderate but rising (debt roughly equal to equity), reducing flexibility. Cash flow has been volatile—negative in 2025, with a TTM recovery but lower free cash flow versus prior strength—keeping near-term execution risk elevated.
Income Statement
44NeutralBalance Sheet
63PositiveCash Flow
39Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.63B | 45.43B | 40.65B | 34.07B | 31.97B | 27.77B |
| Gross Profit | 3.52B | 4.08B | 4.74B | 4.33B | 3.93B | 3.28B |
| EBITDA | 333.00M | 976.00M | 1.89B | 1.74B | 1.35B | 1.13B |
| Net Income | -48.00M | 472.00M | 1.18B | 1.09B | 792.00M | 659.00M |
Balance Sheet | ||||||
| Total Assets | 15.65B | 15.56B | 15.63B | 14.89B | 12.31B | 12.21B |
| Cash, Cash Equivalents and Short-Term Investments | 8.58B | 8.26B | 8.99B | 9.11B | 7.50B | 7.64B |
| Total Debt | 3.95B | 3.95B | 3.12B | 2.38B | 2.39B | 2.39B |
| Total Liabilities | 11.50B | 11.49B | 11.13B | 10.68B | 9.35B | 9.58B |
| Stockholders Equity | 4.16B | 4.07B | 4.50B | 4.21B | 2.96B | 2.63B |
Cash Flow | ||||||
| Free Cash Flow | 238.00M | -636.00M | 544.00M | 1.58B | 682.00M | 2.04B |
| Operating Cash Flow | 331.00M | -535.00M | 644.00M | 1.66B | 773.00M | 2.12B |
| Investing Cash Flow | -98.00M | 312.00M | -464.00M | -744.00M | -790.00M | -1.65B |
| Financing Cash Flow | 61.00M | -170.00M | -347.00M | -58.00M | -441.00M | -183.00M |
Molina Healthcare Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MOH, the sentiment is Positive. The current price of 221.21 is above the 20-day moving average (MA) of 210.39, above the 50-day MA of 203.72, and above the 200-day MA of 186.26, indicating a bullish trend. The MACD of 4.04 indicates Negative momentum. The RSI at 57.20 is Neutral, neither overbought nor oversold. The STOCH value of 61.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MOH.
Molina Healthcare Risk Analysis
Molina Healthcare disclosed 41 risk factors in its most recent earnings report. Molina Healthcare reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
3 New RisksMolina Healthcare Peers Comparison
Overall Rating
ELV76Outperform
CI75Outperform
CNC66Neutral
UNH62Neutral
HUM58Neutral
MOH57Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | $93.75B | 18.45 | 11.59% | 1.58% | 3.60% | -4.06% | |
| 75Outperform | $77.49B | 12.92 | 14.10% | 2.11% | 6.79% | -0.38% | |
| 66Neutral | $35.92B | 24.46 | 6.78% | ― | 9.71% | ― | |
| 62Neutral | $349.16B | 22.14 | 16.35% | 2.33% | 3.33% | -8.75% | |
| 58Neutral | $53.25B | 42.48 | 6.70% | 0.80% | 22.02% | -3.07% | |
| 57Neutral | $11.55B | -364.70 | -1.17% | ― | -0.95% | -105.84% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MOH | Molina Healthcare Inc | 221.21 | 83.09 | 60.16% | |
| CNC | Centene | 72.55 | 36.60 | 101.81% | |
| CI | Cigna | 294.06 | 28.10 | 10.56% | |
| HUM | Humana | 443.34 | 217.39 | 96.21% | |
| UNH | Unitedhealth Group Inc. | 389.68 | 88.61 | 29.43% | |
| ELV | Elevance Health, Inc. | 433.93 | 123.73 | 39.89% |
Molina Healthcare Corporate Events
Molina Healthcare Management to Participate in UBS Healthcare Conference
NeutralMolina Healthcare announced that members of its senior management team were scheduled to participate in UBS’s Global Healthcare Conference on November 9, 2026. The planned investor discussions were to cover the company’s business and financial result...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
